Doctor Harold Bays
Louisville Metabolic and Atherosclerosis Research Center, Louisville (United States of America)
The future of lipid management: new therapies for LDL-C lowering
Event: ESC Congress 2019
Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)
Session: Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population
ESC 365 is supported by
